Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Kenji Sugibayashi
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Physiology
Living Beings
Anatomy
Procedures
Phenomena
Concepts & Ideas
Chemicals & Drugs
Devices
Sign-in to see full Profile
Network (preview)
47
Morimoto, Yasunori
17
Natsume, Hideshi
16
Hasegawa, Tetsuya
13
Todo, Hiroaki
9
Seki, Toshinobu
9
Hayashi, Teruaki
8
Hosoya, Ken-ichi
8
Kobayashi, Daisuke
6
Juni, Kazuhiko
4
Kobayashi, Yoichi
4
Aso, Yoshinori
4
Numajiri, Sachihiko
4
Mitsui, Tetsuya
4
Mori, Kenji
4
Yamaguchi, Koji
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Kenji Sugibayashi (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Ishii Hiroshi; Todo Hiroaki; Terao Akira; Hasegawa Tetuya; Akimoto Masayuki; Oshima Kouichi; Sugibayashi Kenji
Why does a hydrophilic drug permeate skin, although it is not soluble in white petrolatum?
Drug development and industrial pharmacy 2009;35(11):1356-63.
-
2009: Kitamura Toshihiko; Todo Hiroaki; Sugibayashi Kenji
Effect of several electrolyzed waters on the skin permeation of lidocaine, benzoic Acid, and isosorbide mononitrate.
Drug development and industrial pharmacy 2009;35(2):145-53.
-
2008: Yamaguchi Koji; Mitsui Tetsuya; Aso Yoshinori; Sugibayashi Kenji
Structure-permeability relationship analysis of the permeation barrier properties of the stratum corneum and viable epidermis/dermis of rat skin.
Journal of pharmaceutical sciences 2008;97(10):4391-403.
-
2008: Yoshida Daisuke; Todo Hiroaki; Hasegawa Tetsuya; Sugibayashi Kenji
Effect of molecular weight on the dermatopharmacokinetics and systemic disposition of drugs after intracutaneous injection.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2008;35(1-2):5-11.
-
2008: Sugibayashi Kenji; Todo Hiroaki; Kimura Eriko
Safety evaluation of titanium dioxide nanoparticles by their absorption and elimination profiles.
The Journal of toxicological sciences 2008;33(3):293-8.
-
2008: Yoshida Daisuke; Todo Hiroaki; Hasegawa Tetsuya; Sugibayashi Kenji
Effect of vasoactive agents on the dermatopharmacokinetics and systemic disposition of model compounds, salicylate and FITC-dextran 4 kDa, following intracutaneous injection of the compounds.
International journal of pharmaceutics 2008;356(1-2):181-6.
-
2008: Yamaguchi Koji; Morita Keiichi; Mitsui Tetsuya; Aso Yoshinori; Sugibayashi Kenji
Skin permeation and metabolism of a new antipsoriatic vitamin D(3) analogue of structure 16-en-22-oxa-24-carboalkoxide with low calcemic effect.
International journal of pharmaceutics 2008;353(1-2):105-12.
-
2008: Cao Dianxiu; Kitamura Toshihiko; Todo Hiroaki; Yoo Sun Dong; Sugibayashi Kenji
Pretreatment effects of moxibustion on the skin permeation of FITC-dextran.
International journal of pharmaceutics 2008;354(1-2):117-25.
-
2008: Hasegawa Tetsuya; Kawazome Asako; Matsumoto Kaori; Yanagimoto Go; Hayashi Teruaki; Akimoto Masayuki; Todo Hiroaki; Sugibayashi Kenji
Analysis of skin disposition and metabolism of ethyl nicotinate after topical application using dual agar gel disc-inserted rats.
Biological & pharmaceutical bulletin 2008;31(1):85-9.
-
2007: Hasegawa Tetsuya; Kawazome Asako; Yanagimoto Go; Hayashi Teruaki; Seki Toshinobu; Akimoto Masayuki; Todo Hiroaki; Sugibayashi Kenji
Analysis of skin disposition of flurbiprofen after topical application using dual agar gel discs-inserted rats.
Biological & pharmaceutical bulletin 2007;30(11):2135-40.
-
2007: Hada Nobuko; Todo Hiroaki; Komada Fusao; Sugibayashi Kenji
Preparation and evaluation of gene-transfected cultured skin as a novel drug delivery system for severely burned skin.
Pharmaceutical research 2007;24(8):1473-9.
-
2007: Yoshida Daisuke; Todo Hiroaki; Hasegawa Tetsuya; Sugibayashi Kenji
Dermatopharmacokinetics of salicylate following topical injection in rats: effect of osmotic pressure and injection volume on salicylate disposition.
International journal of pharmaceutics 2007;337(1-2):142-7.
-
2007: Yamaguchi Koji; Mitsui Tetsuya; Aso Yoshinori; Sugibayashi Kenji
Analysis of in vitro skin permeation of 22-oxacalcitriol from ointments based on a two- or three-layer diffusion model considering diffusivity in a vehicle.
International journal of pharmaceutics 2007;336(2):310-8.
-
2007: Wu Xue-Ming; Todo Hiroaki; Sugibayashi Kenji
Enhancement of skin permeation of high molecular compounds by a combination of microneedle pretreatment and iontophoresis.
Journal of controlled release : official journal of the Controlled Release Society 2007;118(2):189-95.
-
2006: Tokumoto Seiji; Higo Naruhito; Sugibayashi Kenji
Effect of electroporation and pH on the iontophoretic transdermal delivery of human insulin.
International journal of pharmaceutics 2006;326(1-2):13-9.
-
2006: Akimoto Masayuki; Sato Yuko; Okubo Toshimi; Todo Hiroaki; Hasegawa Tetsuya; Sugibayashi Kenji
Conversion of FAD to FMN and riboflavin in plasma: effects of measuring method.
Biological & pharmaceutical bulletin 2006;29(8):1779-82.
-
2006: Wu Xue-Ming; Todo Hiroaki; Sugibayashi Kenji
Effects of pretreatment of needle puncture and sandpaper abrasion on the in vitro skin permeation of fluorescein isothiocyanate (FITC)-dextran.
International journal of pharmaceutics 2006;316(1-2):102-8.
-
2006: Yamaguchi Koji; Mitsui Tetsuya; Yamamoto Toshinori; Shiokawa Rie; Nomiyama Yuko; Ohishi Norihisa; Aso Yoshinori; Sugibayashi Kenji
Analysis of in vitro skin permeation of 22-oxacalcitriol having a complicated metabolic pathway.
Pharmaceutical research 2006;23(4):680-8.
-
2006: Fujisaki Yuki; Tsukune Tadashi; Funyû Motomu; Okumura Mutsuo; Ukigaya Tadashi; Sugibayashi Kenji
Development of sustained-release tablets containing sodium valproate: in vitro and in vivo correlation.
Drug development and industrial pharmacy 2006;32(2):207-17.
-
2006: Kano Satoshi; Sugibayashi Kenji
Kinetic analysis on the skin disposition of cytotoxicity as an index of skin irritation produced by cetylpyridinium chloride: comparison of in vitro data using a three-dimensional cultured human skin model with in vivo results in hairless mice.
Pharmaceutical research 2006;23(2):329-35.
-
2005: Hada Nobuko; Hasegawa Tetsuya; Takahashi Hidekazu; Ishibashi Takuya; Sugibayashi Kenji
Cultured skin loaded with tetracycline HCl and chloramphenicol as dermal delivery system: mathematical evaluation of the cultured skin containing antibiotics.
Journal of controlled release : official journal of the Controlled Release Society 2005;108(2-3):341-50.
-
2005: Inoue Kazuhiro; Ogawa Kengo; Okada Jun'ichi; Sugibayashi Kenji
Enhancement of skin permeation of ketotifen by supersaturation generated by amorphous form of the drug.
Journal of controlled release : official journal of the Controlled Release Society 2005;108(2-3):306-18.
-
2005: Matsui Rakan; Hasegawa Masaaki; Ishida Masami; Ebata Toshiya; Namiki Noriyuki; Sugibayashi Kenji
Skin permeation of lidocaine from crystal suspended oily formulations.
Drug development and industrial pharmacy 2005;31(8):729-38.
-
2005: Tokumoto Seiji; Mori Kenji; Higo Naruhito; Sugibayashi Kenji
Effect of electroporation on the electroosmosis across hairless mouse skin in vitro.
Journal of controlled release : official journal of the Controlled Release Society 2005;105(3):296-304.
-
2005: Osawa Makiko; Hada Nobuko; Matsumoto Kaori; Hasegawa Tetsuya; Kobayashi Daisuke; Morimoto Yasunori; Yamaguchi Masatoshi; Kanamoto Ikuo; Nakagawa Teruaki; Sugibayashi Kenji
Usefulness of coadministration of bucolome in warfarin therapy: pharmacokinetic and pharmacodynamic analysis using outpatient prescriptions.
International journal of pharmaceutics 2005;293(1-2):43-9.
-
2005: Hasegawa Tetsuya; Kim Soan; Tsuchida Mamoru; Issiki Yasunori; Kondo Seiichi; Sugibayashi Kenji
Decrease in skin permeation and antibacterial effect of parabens by a polymeric additive, poly(2-methacryloyloxyethyl phosphorylcholine-co-butylmetacrylate).
Chemical & pharmaceutical bulletin 2005;53(3):271-6.
-
2005: Homma Masato; Kuga Keisuke; Doki Kosuke; Katori Kumi; Yamaguchi Iwao; Sugibayashi Kenji; Kohda Yukinao
Assessment of serum flecainide trough levels in patients with tachyarrhythmia.
The Journal of pharmacy and pharmacology 2005;57(1):47-51.
-
2004: Sugibayashi Kenji; Hayashi Teruaki; Matsumoto Kaori; Hasegawa Tetsuya
Utility of a three-dimensional cultured human skin model as a tool to evaluate the simultaneous diffusion and metabolism of ethyl nicotinate in skin.
Drug metabolism and pharmacokinetics 2004;19(5):352-62.
-
2004: Kobayashi Yoichi; Komatsu Tsunehisa; Sumi Machiko; Numajiri Sachihiko; Miyamoto Misao; Kobayashi Daisuke; Sugibayashi Kenji; Morimoto Yasunori
In vitro permeation of several drugs through the human nail plate: relationship between physicochemical properties and nail permeability of drugs.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2004;21(4):471-7.
-
2004: Tokudome Yoshihiro; Sugibayashi Kenji
Mechanism of the synergic effects of calcium chloride and electroporation on the in vitro enhanced skin permeation of drugs.
Journal of controlled release : official journal of the Controlled Release Society 2004;95(2):267-74.
-
2003: Tokudome Yoshihiro; Sugibayashi Kenji
The effects of calcium chloride and sodium chloride on the electroporation-mediated skin permeation of fluorescein isothiocyanate (FITC)-dextrans in vitro.
Biological & pharmaceutical bulletin 2003;26(10):1508-10.
-
2003: Tokudome Yoshihiro; Sugibayashi Kenji
The synergic effects of various electrolytes and electroporation on the in vitro skin permeation of calcein.
Journal of controlled release : official journal of the Controlled Release Society 2003;92(1-2):93-101.
-
2003: Mori Kenji; Hasegawa Tetsuya; Sato Shuji; Sugibayashi Kenji
Effect of electric field on the enhanced skin permeation of drugs by electroporation.
Journal of controlled release : official journal of the Controlled Release Society 2003;90(2):171-9.
-
2003: Mori Kenji; Tokumoto Seiji; Kubo Hiroyuki; Higo Naruhito; Nozawa Iwao; Sato Shuji; Sugibayashi Kenji
Design and feasibility assessment of topically applied drug formulations for electroporation.
Chemical & pharmaceutical bulletin 2003;51(6):617-9.
-
2003: Katori Kumi; Homma Masato; Kuga Keisuke; Yamaguchi Iwao; Sugibayashi Kenji; Kohda Yukinao
Liquid chromatographic determination of unbound flecainide in therapeutic drug monitoring.
Journal of pharmaceutical and biomedical analysis 2003;32(2):375-80.
-
2002: Sugibayashi K; Watanabe T; Hasegawa T; Takahashi H; Ishibashi T
Kinetic analysis on the in vitro cytotoxicity using Living Skin Equivalent for ranking the toxic potential of dermal irritants.
Toxicology in vitro : an international journal published in association with BIBRA 2002;16(6):759-63.
-
2002: Jin Yi; Ohkuma Hideki; Wang Hua; Natsume Hideshi; Sugibayashi Kenji; Morimoto Yasunori
[Fast-disintegration oral tablets having sustained release property]
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2002;122(11):989-94.
-
2002: Fang Liang; Kobayashi Yoichi; Numajiri Sachihiko; Kobayashi Daisuke; Sugibayashi Kenji; Morimoto Yasunori
The enhancing effect of a triethanolamine-ethanol-isopropyl myristate mixed system on the skin permeation of acidic drugs.
Biological & pharmaceutical bulletin 2002;25(10):1339-44.
-
2002: Uchida Masaki; Jin Yi; Natsume Hideshi; Kobayashi Daisuke; Sugibayashi Kenji; Morimoto Yasunori
Introduction of poly-L-lactic acid microspheres into the skin using supersonic flow: effects of helium gas pressure, particle size and microparticle dose on the amount introduced into hairless rat skin.
The Journal of pharmacy and pharmacology 2002;54(6):781-90.
-
2002: Watanabe Tetsuya; Hasegawa Tetsuya; Takahashi Hidekazu; Ishibashi Takuya; Itagaki Hiroshi; Sugibayashi Kenji
Utility of MTT assay in three-dimensional cultured human skin model as an alternative for draize skin irritation test: approach using diffusion law of irritant in skin and toxicokinetics-toxicodynamics correlation.
Pharmaceutical research 2002;19(5):669-75.
-
2002: Uchida Masaki; Natsume Hideshi; Kobayashi Daisuke; Sugibayashi Kenji; Morimoto Yasunori
Effects of particle size, helium gas pressure and microparticle dose on the plasma concentration of indomethacin after bombardment of indomethacin-loaded poly-L-lactic acid microspheres using a Helios gun system.
Biological & pharmaceutical bulletin 2002;25(5):690-3.
-
2002: Morimoto Yasunori; Wada Yoshio; Seki Toshinobu; Sugibayashi Kenji
In vitro skin permeation of morphine hydrochloride during the finite application of penetration-enhancing system containing water, ethanol and l-menthol.
Biological & pharmaceutical bulletin 2002;25(1):134-6.
-
2002: Yoshida Daisuke; Hasegawa Tetsuya; Sugibayashi Kenji
Targeting of salicylate to skin and muscle following topical injections in rats.
International journal of pharmaceutics 2002;231(2):177-84.
-
2001: Miyamoto M; Natsume H; Satoh I; Ohtake K; Yamaguchi M; Kobayashi D; Sugibayashi K; Morimoto Y
Effect of poly-L-arginine on the nasal absorption of FITC-dextran of different molecular weights and recombinant human granulocyte colony-stimulating factor (rhG-CSF) in rats.
International journal of pharmaceutics 2001;226(1-2):127-38.
-
2001: Jin Y; Ohkuma H; Wang C F; Natsume H; Sugibayashi K; Morimoto Y
[Pharmaceutical evaluation of fast-disintegrant tablet containing nicorandil-loaded particles]
Yao xue xue bao = Acta pharmaceutica Sinica 2001;36(7):535-8.
-
2001: Miyamoto M; Natsume H; Iwata S; Ohtake K; Yamaguchi M; Kobayashi D; Sugibayashi K; Yamashina M; Morimoto Y
Improved nasal absorption of drugs using poly-L-arginine: effects of concentration and molecular weight of poly-L-arginine on the nasal absorption of fluorescein isothiocyanate-dextran in rats.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2001;52(1):21-30.
-
2001: Sato K; Mitsui N; Hasegawa T; Sugibayashi K; Morimoto Y
Potential usefulness of solubility index for prediction of the skin permeation rate of 5-ISMN from pressure-sensitive adhesive tape.
Journal of controlled release : official journal of the Controlled Release Society 2001;73(2-3):269-77.
-
2001: Sugibayashi K; Yoshida M; Mori K; Watanabe T; Hasegawa T
Electric field analysis on the improved skin concentration of benzoate by electroporation.
International journal of pharmaceutics 2001;219(1-2):107-12.
-
2001: Jin Y; Uchida M; Wang C F; Natsume H; Sugibayashi K; Morimoto Y
[Transdermal microparticle delivery by a supersonic-Helios gun system]
Yao xue xue bao = Acta pharmaceutica Sinica 2001;36(2):140-4.
-
2000: Ohmori S; Hayashi T; Kawase M; Saito S; Sugibayashi K; Morimoto Y
Transdermal delivery of the potent analgesic dihydroetorphine: kinetic analysis of skin permeation and analgesic effect in the hairless rat.
The Journal of pharmacy and pharmacology 2000;52(12):1437-49.
-
2000: Sugibayashi K; Kagino M; Numajiri S; Inoue N; Kobayashi D; Kimura M; Yamaguchi M; Morimoto Y
Synergistic effects of iontophoresis and jet injector pretreatment on the in-vitro skin permeation of diclofenac and angiotensin II.
The Journal of pharmacy and pharmacology 2000;52(10):1179-86.
-
2000: Manabe E; Numajiri S; Sugibayashi K; Morimoto Y
Analysis of skin permeation-enhancing mechanism of iontophoresis using hydrodynamic pore theory.
Journal of controlled release : official journal of the Controlled Release Society 2000;66(2-3):149-58.
-
1999: Sugibayashi K; Hayashi T; Morimoto Y
Simultaneous transport and metabolism of ethyl nicotinate in hairless rat skin after its topical application: the effect of enzyme distribution in skin.
Journal of controlled release : official journal of the Controlled Release Society 1999;62(1-2):201-8.
-
1999: Sugibayashi K; Yanagimoto G; Hayashi T; Seki T; Juni K; Morimoto Y
Analysis of skin disposition of flurbiprofen after topical application in hairless rats.
Journal of controlled release : official journal of the Controlled Release Society 1999;62(1-2):193-200.
-
1999: Hosoya K; Kubo H; Natsume H; Sugibayashi K; Morimoto Y
Evaluation of bile acids and fusidate derivative as nasal absorption enhancers using an electrophysiological technique.
Biological & pharmaceutical bulletin 1999;22(10):1089-93.
-
1999: Sakuma K; Ogawa M; Sugibayashi K; Yamada K; Yamamoto K
Relationship between tyrosinase inhibitory action and oxidation-reduction potential of cosmetic whitening ingredients and phenol derivatives.
Archives of pharmacal research 1999;22(4):335-9.
-
1999: Natsume H; Iwata S; Ohtake K; Miyamoto M; Yamaguchi M; Hosoya K; Kobayashi D; Sugibayashi K; Morimoto Y
Screening of cationic compounds as an absorption enhancer for nasal drug delivery.
International journal of pharmaceutics 1999;185(1):1-12.
-
1999: Yanagimoto G; Hayashi T; Hasegawa T; Seki T; Juni K; Sugibayashi K; Morimoto Y
Skin disposition of drugs after topical application in hairless rats.
Chemical & pharmaceutical bulletin 1999;47(6):749-54.
-
1999: Kobayashi Y; Miyamoto M; Sugibayashi K; Morimoto Y
Drug permeation through the three layers of the human nail plate.
The Journal of pharmacy and pharmacology 1999;51(3):271-8.
-
1998: Kobayashi Y; Miyamoto M; Sugibayashi K; Morimoto Y
Enhancing effect of N-acetyl-l-cysteine or 2-mercaptoethanol on the in vitro permeation of 5-fluorouracil or tolnaftate through the human nail plate.
Chemical & pharmaceutical bulletin 1998;46(11):1797-802.
-
1998: Hosoya O; Sano M; Wada Y; Seki T; Sugibayashi K; Juni K; Morimoto Y
Effect of several hydrophilic polymers on the permeation of morphine and salicylic acid through excised hairless rat skin.
Chemical & pharmaceutical bulletin 1998;46(5):882-5.
-
1998: Sugibayashi K; Morimoto Y
[Transdermal therapeutic systems]
Nippon rinsho. Japanese journal of clinical medicine 1998;56(3):619-27.
-
1997: Yamaguchi Y; Usami T; Natsume H; Aoyagi T; Nagase Y; Sugibayashi K; Morimoto Y
Evaluation of skin permeability of drugs by newly prepared polymer membranes.
Chemical & pharmaceutical bulletin 1997;45(3):537-41.
-
1996: Ueda H; Ogihara M; Sugibayashi K; Morimoto Y
Difference in the enhancing effects of ultrasound on the skin permeation of polar and non-polar drugs.
Chemical & pharmaceutical bulletin 1996;44(10):1973-6.
-
1996: Numajiri S; Sugibayashi K; Morimoto Y
Analysis of in vitro iontophoretic skin permeation of sodium benzoate by transport numbers of drug and additives.
Chemical & pharmaceutical bulletin 1996;44(7):1351-6.
-
1996: Sugibayashi K; Hayashi T; Hatanaka T; Ogihara M; Morimoto Y
Analysis of simultaneous transport and metabolism of ethyl nicotinate in hairless rat skin.
Pharmaceutical research 1996;13(6):855-60.
-
1994: Hatanaka T; Manabe E; Sugibayashi K; Morimoto Y
An application of the hydrodynamic pore theory to percutaneous absorption of drugs.
Pharmaceutical research 1994;11(5):654-8.
-
1994: Hosoya K; Kubo H; Akutsu T; Natsume H; Sugibayashi K; Morimoto Y
Effect of sodium taurodihydrofusidate on nasal drug delivery: differences in its concentration and penetrant molecular weight.
Archives of pharmacal research 1994;17(2):57-9.
-
1994: Hosoya K; Kubo H; Natsume H; Sugibayashi K; Morimoto Y
Evaluation of enhancers to increase nasal absorption using Ussing chamber technique.
Biological & pharmaceutical bulletin 1994;17(2):316-22.
-
1994: Kobayashi D; Matsuzawa T; Sugibayashi K; Morimoto Y; Kimura M
Analysis of the combined effect of 1-menthol and ethanol as skin permeation enhancers based on a two-layer skin model.
Pharmaceutical research 1994;11(1):96-103.
-
1994: Morimoto Y; Sugibayashi K; Natsume H
The transdermal drug delivery system and transcutaneous absorption.
Acta dermato-venereologica. Supplementum 1994;185():15-7.
-
1993: Hosoya K; Kubo H; Natsume H; Sugibayashi K; Morimoto Y; Yamashita S
The structural barrier of absorptive mucosae: site difference of the permeability of fluorescein isothiocyanate-labelled dextran in rabbits.
Biopharmaceutics & drug disposition 1993;14(8):685-95.
-
1993: Numajiri S; Sugibayashi K; Morimoto Y
Non-invasive sampling of lactic acid ions by iontophoresis using chloride ion in the body as an internal standard.
Journal of pharmaceutical and biomedical analysis 1993;11(10):903-9.
-
1993: Numajiri S; Sakurai H; Sugibayashi K; Morimoto Y; Omiya H; Takenaka H; Akiyama N
Comparison of depolarizing and direct current systems on iontophoretic enhancement of transport of sodium benzoate through human and hairless rat skin.
The Journal of pharmacy and pharmacology 1993;45(7):610-3.
-
1993: Kobayashi D; Matsuzawa T; Sugibayashi K; Morimoto Y; Kobayashi M; Kimura M
Feasibility of use of several cardiovascular agents in transdermal therapeutic systems with l-menthol-ethanol system on hairless rat and human skin.
Biological & pharmaceutical bulletin 1993;16(3):254-8.
-
1993: Natsume H; Imamizu M; Sugibayashi K; Shibata T; Miyagawa A; Morimoto Y
Selective accumulation and tumoricidal effect of cisplatin suspended in viscous ethyl oleate on hepatic cancers in animals after intraarterial infusion.
Journal of drug targeting 1993;1(3):207-15.
-
1992: Hayashi T; Sugibayashi K; Morimoto Y
Calculation of skin permeability coefficient for ionized and unionized species of indomethacin.
Chemical & pharmaceutical bulletin 1992;40(11):3090-3.
-
1992: Morimoto Y; Hatanaka T; Sugibayashi K; Omiya H
Prediction of skin permeability of drugs: comparison of human and hairless rat skin.
The Journal of pharmacy and pharmacology 1992;44(8):634-9.
-
1992: Natsume H; Imamizu M; Sugibayashi K; Shibata T; Miyagawa A; Morimoto Y
Oily drug carriers in cancer chemotherapy. II. Preparation of viscous ethyl oleate for intraarterial infusion therapy and its disposition in rats and hamsters.
Chemical & pharmaceutical bulletin 1992;40(6):1545-52.
-
1992: Sugibayashi K; Nakayama S; Seki T; Hosoya K; Morimoto Y
Mechanism of skin penetration-enhancing effect by laurocapram.
Journal of pharmaceutical sciences 1992;81(1):58-64.
-
1991: Hatanaka T; Oguchi M; Sugibayashi K; Morimoto Y
Influence of isosorbide dinitrate concentration on its skin permeability from adhesive matrix devices.
Chemical & pharmaceutical bulletin 1991;39(7):1802-5.
-
1991: Natsume H; Sugibayashi K; Morimoto Y
In vitro release profile of mitomycin C from albumin microspheres: extrapolation from macrospheres to microspheres.
Pharmaceutical research 1991;8(2):185-90.
-
1991: Sato K; Sugibayashi K; Morimoto Y
Species differences in percutaneous absorption of nicorandil.
Journal of pharmaceutical sciences 1991;80(2):104-7.
-
1990: Hatanaka T; Inuma M; Sugibayashi K; Morimoto Y
Prediction of skin permeability of drugs. I. Comparison with artificial membrane.
Chemical & pharmaceutical bulletin 1990;38(12):3452-9.
-
1990: Seki T; Toeda C; Kawaguchi T; Juni K; Sugibayashi K; Morimoto Y
Enhanced transdermal delivery of zidovudine in rats and human skin.
Chemical & pharmaceutical bulletin 1990;38(11):3086-9.
-
1990: Seki T; Kawaguchi T; Sugibayashi K; Juni K; Morimoto Y
Membrane permeation-controlled transdermal delivery system design. Influence of controlling membrane and adhesive on skin permeation of isosorbide dinitrate.
Chemical & pharmaceutical bulletin 1990;38(3):740-3.
-
1989: Sato K; Sugibayashi K; Morimoto Y; Omiya H; Enomoto N
Prediction of the in-vitro human skin permeability of nicorandil from animal data.
The Journal of pharmacy and pharmacology 1989;41(6):379-83.
-
1989: Seki T; Sugibayashi K; Juni K; Morimoto Y
Percutaneous absorption enhancer applied to membrane permeation-controlled transdermal delivery of nicardipine hydrochloride.
Drug design and delivery 1989;4(1):69-75.
-
1989: Sugibayashi K; Sakanoue C; Morimoto Y
Utility of topical formulations of morphine hydrochloride containing azone and N-methyl-2-pyrrolidone.
Selective cancer therapeutics 1989;5(3):119-28.
-
1987: Hosoya K; Shudo N; Sugibayashi K; Morimoto Y
Effect of Azone on the percutaneous absorption of 5-fluorouracil from gels in hairless rats.
Chemical & pharmaceutical bulletin 1987;35(2):726-33.
-
1985: Sugibayashi K; Hosoya K; Morimoto Y; Higuchi W I
Effect of the absorption enhancer, Azone, on the transport of 5-fluorouracil across hairless rat skin.
The Journal of pharmacy and pharmacology 1985;37(8):578-80.
Sign-in to see more
